Jeevan Scientific Technology has informed that USFDA conducted an un-announced audit of its Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at its facilities. The auditors started the review on 20th January, 2020 and completed on 24th January, 2020 Audit concluded with ‘No Observations’ and Auditors are pleased with company procedures. This Audit is specifically to access and approve the bioequivalence studies conducted by JSTL for Pharmaceutical companies across the globe.
The above information is a part of company’s filings submitted to BSE.